AT2030 Venture Spotlight Series featuring JOGO Health

AT2030 Venture spotlight series

This AT2030 Spotlight Series profiles growth-stage assistive technology businesses developing practical technologies and business models to meet unmet access needs at scale. Each case study explores the problem they are addressing, the model they are building, the evidence behind their work, and how AT2030, GDI Hub and GDI Accelerate are supporting their growth trajectory.

JOGO Health

JOGO Health is a digital therapeutics company developing a platform for chronic pain and neuromuscular conditions that aims to reduce reliance on medication and invasive procedures. Operating across the US and India, the company combines wearable muscle sensors, guided therapy, and remote clinician oversight to support ongoing treatment beyond the clinic. Their work focuses on extending care between appointments, enabling patients to continue structured therapy at home while remaining connected to their clinical team. In doing so, JOGO responds to a growing need for non-pharmacological approaches to long-term condition management.